Insider · CIK 0001375378

Gitman Paul

Reports to the SEC for 1 company · MANHASSET HILLS, NY

sec.gov

Transactions

Companies

Filings

CIK

0001375378

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-12-02	BIOSPECIFICS TECHNOLOGIES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−16.9K sh	—	—	1,726
2020-12-02	BIOSPECIFICS TECHNOLOGIES CORPD Disposition to Issuer	Director	DDisposition to Issuer	−1,726 sh	—	—	0
2020-07-15	BIOSPECIFICS TECHNOLOGIES CORPA Award	Director	AAward	+1,726 sh	—	—	18,616
2019-07-01	BIOSPECIFICS TECHNOLOGIES CORPA Award	Director	AAward	+1,890 sh	—	—	16,890
2019-05-15	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,000 sh	$65.83	−$329K	15,000
2018-09-07	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−1,000 sh	$57.64	−$57.6K	20,000
2018-08-29	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,000 sh	$49.79	−$249K	20,000
2018-08-29	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−4,000 sh	$49.79	−$199K	21,000
2018-08-28	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,000 sh	$48.88	−$244K	25,000
2018-08-28	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,000 sh	$48.88	−$244K	25,000
2018-08-27	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−10K sh	$50.11	−$501K	30,000
2018-08-27	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−10K sh	$50.11	−$501K	30,000
2018-08-24	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−6,400 sh	$51.09	−$327K	40,000
2018-08-24	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−6,400 sh	$51.09	−$327K	40,000
2018-08-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,425 sh	$51.27	−$278K	46,400
2018-08-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,425 sh	$51.27	−$278K	46,400
2015-07-20	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,692 sh	—	—	0
2015-07-20	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−8,692 sh	$53.00	−$461K	51,825
2015-07-20	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+8,692 sh	$13.60	+$118K	60,517
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−6,308 sh	$53.59	−$338K	81,825
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+6,308 sh	$13.60	+$85.8K	58,133
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$26.43	+$396K	73,133
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$20.00	+$300K	88,133
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−15K sh	$51.84	−$778K	66,825
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−15K sh	$50.95	−$764K	51,825
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,308 sh	—	—	8,692
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2015-06-23	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2015-05-29	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−11K sh	$46.75	−$514K	55,825
2015-05-29	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−4,000 sh	$46.79	−$187K	51,825
2015-05-27	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−24K sh	$42.00	−$1.01M	66,825
2015-05-27	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	$4.00	+$96K	90,825
2015-05-27	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	0
2015-01-26	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,887 sh	—	—	0
2015-01-26	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+5,887 sh	$1.00	+$5,887	66,825
2015-01-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−5,887 sh	$41.00	−$241K	60,938
2015-01-20	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+4,113 sh	$1.00	+$4,113	66,825
2015-01-20	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,113 sh	—	—	5,887
2015-01-16	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−4,113 sh	$41.00	−$169K	62,712
2014-11-24	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−100 sh	$40.00	−$4,000	74,325
2014-11-24	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−7,500 sh	$39.50	−$296K	66,825
2014-11-12	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2014-11-12	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.15	+$77.3K	74,425
2014-01-23	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+7,804 sh	$1.00	+$7,804	67,229
2014-01-23	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,804 sh	—	—	20,000
2014-01-23	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−7,804 sh	$25.00	−$195K	59,425
2014-01-22	BIOSPECIFICS TECHNOLOGIES CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,196 sh	$1.00	+$2,196	61,621
2014-01-22	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−2,196 sh	$25.00	−$54.9K	59,425
2014-01-22	BIOSPECIFICS TECHNOLOGIES CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,196 sh	—	—	27,804
2013-12-09	BIOSPECIFICS TECHNOLOGIES CORPS Sale	Director	SSale	−15K sh	$23.00	−$345K	59,425

Recent filings

Accepted (ET)
Dec 24
Gitman Paul0000899243-20-032450
SEC(opens sec.gov)
Jul 174
Gitman Paul0000899243-20-019552
SEC(opens sec.gov)
Jul 24
Gitman Paul0001062993-19-002779
SEC(opens sec.gov)
May 174
Gitman Paul0001062993-19-002332
SEC(opens sec.gov)
Sep 74
Gitman Paul0001062993-18-003670
SEC(opens sec.gov)
Aug 294
Gitman Paul0001062993-18-003575
SEC(opens sec.gov)
Aug 294/A
Gitman Paul0001062993-18-003579
SEC(opens sec.gov)
Aug 294/A
Gitman Paul0001062993-18-003581
SEC(opens sec.gov)
Aug 274
Gitman Paul0001062993-18-003555
SEC(opens sec.gov)
Jul 214
BIOSPECIFICS TECHNOLOGIES CORP0001062993-15-003950
SEC(opens sec.gov)
Jun 254
BIOSPECIFICS TECHNOLOGIES CORP0001062993-15-003576
SEC(opens sec.gov)

Companies

BIOSPECIFICS TECHNOLOGIES CORPDirector

Address

167 EXECUTIVE DRIVE

MANHASSET HILLS, NY, 11040